Literature DB >> 2540137

Treatment of systemic yeast infection with fluconazole.

J Cohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2540137     DOI： 10.1093/jac/23.2.294

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

3.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

4.  Penetration of oral fluconazole into gynecological tissues.

Authors:  H Mikamo; K Kawazoe; Y Sato; K Izumi; T Ito; K Ito; T Tamaya
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 5.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

6.  Fluconazole treatment of candidal infections caused by non-albicans Candida species.

Authors:  J W van 't Wout
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 7.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

Review 8.  Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.

Authors:  F N Vincent-Ballereau; O N Patey; C Lafaix
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

9.  Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.

Authors:  P F Troke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 5.103

10.  Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.

Authors:  Nancy A Chow; José F Muñoz; Anastasia P Litvintseva; Christina A Cuomo; Lalitha Gade; Elizabeth L Berkow; Xiao Li; Rory M Welsh; Kaitlin Forsberg; Shawn R Lockhart; Rodney Adam; Alexandre Alanio; Ana Alastruey-Izquierdo; Sahar Althawadi; Ana Belén Araúz; Ronen Ben-Ami; Amrita Bharat; Belinda Calvo; Marie Desnos-Ollivier; Patricia Escandón; Dianne Gardam; Revathi Gunturu; Christopher H Heath; Oliver Kurzai; Ronny Martin
Journal:  mBio       Date:  2020-04-28       Impact factor: 7.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.